1.
Emerg Infect Dis
; 29(8): 1708-1711, 2023 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37486233
RESUMO
We report extensively drug-resistant (XDR) Shigella sonnei infection in an immunocompromised patient in Texas, USA. Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry failed to identify XDR Shigella, but whole-genome sequencing accurately characterized the strain. First-line antimicrobials are not effective against emerging XDR Shigella. Fosfomycin, carbapenems, and tigecycline are potential alternatives.